LOW-VOLUME · HOSP-HEAVY
lemborexant Side Effects
lemborexant (also sold as Dayvigo) is a LOW-VOLUME FAERS extract #443 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 43.9% mention hospitalization (1,064 reports).
Data updated 2026-05-15
- 2,425
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
lemborexant: 43.9% mention hospitalization (1,064 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #443 of 524 by FAERS report count.
Thinner FAERS extract for lemborexant (Dayvigo) (2,425 reports #443 of 524 by FAERS report count). 43.9% mention hospitalization (1,064 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2015–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
SUICIDE ATTEMPT leads 133 of 2,425 reports
Who reports · age peak 65-74 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 65-74 (474 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (267 reports, 11.0%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 32 |
| PNEUMONIA | 22 |
| INTERSTITIAL LUNG DISEASE | 20 |
| DECREASED APPETITE | 17 |
| PNEUMONIA ASPIRATION | 17 |
| CYTOKINE RELEASE SYNDROME | 15 |
| PYREXIA | 15 |
| COMPLETED SUICIDE | 12 |
| FALL | 12 |
| HEPATIC FUNCTION ABNORMAL | 11 |
| NAUSEA | 11 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 10 |
| PLEURAL EFFUSION | 10 |
| CARDIAC FAILURE | 9 |
| MALIGNANT NEOPLASM PROGRESSION | 9 |
| SEPSIS | 9 |
| CEREBRAL INFARCTION | 8 |
| DIARRHOEA | 8 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 8 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (1,064, 43.9% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| SUICIDE ATTEMPT | 120 |
| CONDITION AGGRAVATED | 105 |
| SUICIDAL IDEATION | 101 |
| ADVERSE DRUG REACTION | 58 |
| FALL | 53 |
| PYREXIA | 49 |
| ALTERED STATE OF CONSCIOUSNESS | 47 |
| PNEUMONIA | 44 |
| DECREASED APPETITE | 41 |
| INTENTIONAL OVERDOSE | 41 |
| INTERSTITIAL LUNG DISEASE | 41 |
| SOMNOLENCE | 39 |
| MALAISE | 36 |
| OVERDOSE | 36 |
| DIZZINESS | 34 |
| HEPATIC FUNCTION ABNORMAL | 33 |
| DIARRHOEA | 32 |
| UNDERDOSE | 31 |
How to read lemborexant FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 2,425 voluntary reports linked to lemborexant (Dayvigo), 2015-2025. Death is listed on 267 (11.0%). Hospitalization appears on 1,064 (43.9%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with lemborexant
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 2,415 FAERS cases (Δ 10 lighter vs lemborexant); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 2,439 FAERS cases (Δ 14 heavier vs lemborexant); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 2,450 FAERS cases (Δ 25 heavier vs lemborexant); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 2,398 FAERS cases (Δ 27 lighter vs lemborexant); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 51.1 pp vs lemborexant's DEATH-HEAVY): CASELOAD · HOSP-MID.
lemborexant stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.